Beren Therapeutics Presents New Adrabetadex Data Showing Preservation of Neurological Function for More Than 10 Years in Children with Infantile-Onset NPC

Beren Therapeutics Presents New Adrabetadex Data Showing Preservation of Neurological Function for More Than 10 Years in Children with Infantile-Onset NPC

A case study presented at Child Neurology Society Annual Meeting demonstrates preservation of neurological function in sisters with infantile-onset Niemann-Pick disease, type C Additional data presentations reinforce benefit of early and sustained adrabetadex treatment in preserving function and improving long-term outcomes THOUSAND OAKS, Calif. — Beren Therapeutics P.B.C., a leader in cholesterol-trafficking biology and novel […]